Cargando…

Quantitative Electroencephalography as a Biomarker for Cognitive Dysfunction in Parkinson’s Disease

Background: Quantitative electroencephalography (qEEG) has been suggested as a biomarker for cognitive decline in Parkinson’s disease (PD). Objective: Determine if applying a wavelet-based qEEG algorithm to 21-electrode, resting-state EEG recordings obtained in a routine clinical setting has utility...

Descripción completa

Detalles Bibliográficos
Autores principales: Novak, Kevin, Chase, Bruce A., Narayanan, Jaishree, Indic, Premananda, Markopoulou, Katerina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761986/
https://www.ncbi.nlm.nih.gov/pubmed/35046794
http://dx.doi.org/10.3389/fnagi.2021.804991
_version_ 1784633659990474752
author Novak, Kevin
Chase, Bruce A.
Narayanan, Jaishree
Indic, Premananda
Markopoulou, Katerina
author_facet Novak, Kevin
Chase, Bruce A.
Narayanan, Jaishree
Indic, Premananda
Markopoulou, Katerina
author_sort Novak, Kevin
collection PubMed
description Background: Quantitative electroencephalography (qEEG) has been suggested as a biomarker for cognitive decline in Parkinson’s disease (PD). Objective: Determine if applying a wavelet-based qEEG algorithm to 21-electrode, resting-state EEG recordings obtained in a routine clinical setting has utility for predicting cognitive impairment in PD. Methods: PD subjects, evaluated by disease stage and motor score, were compared to healthy controls (N = 20 each). PD subjects with normal (PDN, MoCA 26–30, N = 6) and impaired (PDD, MoCA ≤ 25, N = 14) cognition were compared. The wavelet-transform based time-frequency algorithm assessed the instantaneous predominant frequency (IPF) at 60 ms intervals throughout entire recordings. We then determined the relative time spent by the IPF in the four standard EEG frequency bands (RTF) at each scalp location. The resting occipital rhythm (ROR) was assessed using standard power spectral analysis. Results: Comparing PD subjects to healthy controls, mean values are decreased for ROR and RTF-Beta, greater for RTF-Theta and similar for RTF-Delta and RTF-Alpha. In logistic regression models, arithmetic combinations of RTF values [e.g., (RTF-Alpha) + (RTF-Beta)/(RTF-Delta + RTF-Theta)] and RTF-Alpha values at occipital or parietal locations are most able to discriminate between PD and controls. A principal component (PC) from principal component analysis (PCA) using RTF-band values in all subjects is associated with PD status (p = 0.004, β = 0.31, AUC = 0.780). Its loadings show positive contribution from RTF-Theta at all scalp locations, and negative contributions from RTF-Beta at occipital, parietal, central, and temporal locations. Compared to cognitively normal PD subjects, cognitively impaired PD subjects have lower median RTF-Alpha and RTF-Beta values, greater RTF-Theta values and similar RTF-Delta values. A PC from PCA using RTF-band values in PD subjects is associated with cognitive status (p = 0.002, β = 0.922, AUC = 0.89). Its loadings show positive contributions from RTF-Theta at all scalp locations, negative contributions from RTF-Beta at central locations, and negative contributions from RTF-Delta at central, frontal and temporal locations. Age, disease duration and/or sex are not significant covariates. No PC was associated with motor score or disease stage. Significance: Analyzing standard EEG recordings obtained in a community practice setting using a wavelet-based qEEG algorithm shows promise as a PD biomarker and for predicting cognitive impairment in PD.
format Online
Article
Text
id pubmed-8761986
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-87619862022-01-18 Quantitative Electroencephalography as a Biomarker for Cognitive Dysfunction in Parkinson’s Disease Novak, Kevin Chase, Bruce A. Narayanan, Jaishree Indic, Premananda Markopoulou, Katerina Front Aging Neurosci Neuroscience Background: Quantitative electroencephalography (qEEG) has been suggested as a biomarker for cognitive decline in Parkinson’s disease (PD). Objective: Determine if applying a wavelet-based qEEG algorithm to 21-electrode, resting-state EEG recordings obtained in a routine clinical setting has utility for predicting cognitive impairment in PD. Methods: PD subjects, evaluated by disease stage and motor score, were compared to healthy controls (N = 20 each). PD subjects with normal (PDN, MoCA 26–30, N = 6) and impaired (PDD, MoCA ≤ 25, N = 14) cognition were compared. The wavelet-transform based time-frequency algorithm assessed the instantaneous predominant frequency (IPF) at 60 ms intervals throughout entire recordings. We then determined the relative time spent by the IPF in the four standard EEG frequency bands (RTF) at each scalp location. The resting occipital rhythm (ROR) was assessed using standard power spectral analysis. Results: Comparing PD subjects to healthy controls, mean values are decreased for ROR and RTF-Beta, greater for RTF-Theta and similar for RTF-Delta and RTF-Alpha. In logistic regression models, arithmetic combinations of RTF values [e.g., (RTF-Alpha) + (RTF-Beta)/(RTF-Delta + RTF-Theta)] and RTF-Alpha values at occipital or parietal locations are most able to discriminate between PD and controls. A principal component (PC) from principal component analysis (PCA) using RTF-band values in all subjects is associated with PD status (p = 0.004, β = 0.31, AUC = 0.780). Its loadings show positive contribution from RTF-Theta at all scalp locations, and negative contributions from RTF-Beta at occipital, parietal, central, and temporal locations. Compared to cognitively normal PD subjects, cognitively impaired PD subjects have lower median RTF-Alpha and RTF-Beta values, greater RTF-Theta values and similar RTF-Delta values. A PC from PCA using RTF-band values in PD subjects is associated with cognitive status (p = 0.002, β = 0.922, AUC = 0.89). Its loadings show positive contributions from RTF-Theta at all scalp locations, negative contributions from RTF-Beta at central locations, and negative contributions from RTF-Delta at central, frontal and temporal locations. Age, disease duration and/or sex are not significant covariates. No PC was associated with motor score or disease stage. Significance: Analyzing standard EEG recordings obtained in a community practice setting using a wavelet-based qEEG algorithm shows promise as a PD biomarker and for predicting cognitive impairment in PD. Frontiers Media S.A. 2022-01-03 /pmc/articles/PMC8761986/ /pubmed/35046794 http://dx.doi.org/10.3389/fnagi.2021.804991 Text en Copyright © 2022 Novak, Chase, Narayanan, Indic and Markopoulou. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Novak, Kevin
Chase, Bruce A.
Narayanan, Jaishree
Indic, Premananda
Markopoulou, Katerina
Quantitative Electroencephalography as a Biomarker for Cognitive Dysfunction in Parkinson’s Disease
title Quantitative Electroencephalography as a Biomarker for Cognitive Dysfunction in Parkinson’s Disease
title_full Quantitative Electroencephalography as a Biomarker for Cognitive Dysfunction in Parkinson’s Disease
title_fullStr Quantitative Electroencephalography as a Biomarker for Cognitive Dysfunction in Parkinson’s Disease
title_full_unstemmed Quantitative Electroencephalography as a Biomarker for Cognitive Dysfunction in Parkinson’s Disease
title_short Quantitative Electroencephalography as a Biomarker for Cognitive Dysfunction in Parkinson’s Disease
title_sort quantitative electroencephalography as a biomarker for cognitive dysfunction in parkinson’s disease
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761986/
https://www.ncbi.nlm.nih.gov/pubmed/35046794
http://dx.doi.org/10.3389/fnagi.2021.804991
work_keys_str_mv AT novakkevin quantitativeelectroencephalographyasabiomarkerforcognitivedysfunctioninparkinsonsdisease
AT chasebrucea quantitativeelectroencephalographyasabiomarkerforcognitivedysfunctioninparkinsonsdisease
AT narayananjaishree quantitativeelectroencephalographyasabiomarkerforcognitivedysfunctioninparkinsonsdisease
AT indicpremananda quantitativeelectroencephalographyasabiomarkerforcognitivedysfunctioninparkinsonsdisease
AT markopouloukaterina quantitativeelectroencephalographyasabiomarkerforcognitivedysfunctioninparkinsonsdisease